latest aidsmap news

• High rate of death amongst patients with HIV diagnosed late
• CD4 cell count increases sustained up to five years in developing-world treatment programmes
• Raltegravir may have role in PEP if exposure involves drug-resistant HIV
• Excellent outcomes from five years of antiretroviral use in Botswana
• Study explores verbal and non-verbal communication in unprotected sex between men
• IL-2 provides quick ‘AIDS rescue’, but effect does not always last
• Once-a-day etravirine should work as first-line treatment
• Second-line combinations fail twice as often as first-line ones in the first year
• If you can't switch, better to stay on failing treatment than stop it, studies show
• Non-nucleoside resistance is efficiently transmitted within infection ‘clusters’